Loading patent…
AssigneeBio-Virus Research Incorporated
InventorMark Shlyankevich
Estimating the term…
A composition is disclosed for controlling the stimulation of estrogen production, which comprises: (a) 15 to 120 parts by weight of one or more phytoestrogen compounds calculated as a free aglycon form of isoflavone; (b) up to 75 parts by weight of dried licorice root extract; (c) 10 to 80 parts by weight of a sedative selected from the group consisting of Valerian root dry extract, passion flower dry extract, and Ginseng root powder; (d) up to 50, preferably 10 to 20 parts by weight of beta-carotene; (e) up to 200, preferably 15 to 150 parts by weight of pyridoxine hydrochloride; (f) up to 50, preferably 12 to 30 parts by weight of Vitamin E; (g) up to 600, preferably 100 to 450 parts by weight of calcium contained in a biologically acceptable calcium salt; (h) up to 200, preferably 150 to 250 parts by weight of magnesium contained in a biologically acceptable magnesium salt; (i) up to 100, preferably 10 to 50 parts by weight of zinc contained in a biologically acceptable zinc salt; (j) up to 30 parts by weight of coumestan; and (k) up to 50 parts by weight of pantothenic acid; in admixture with a biologically acceptable inert carrier.
A composition for controlling the stimulation of estrogen production, which comprises:
A composition for controlling the stimulation of estrogen production which comprises:
A composition for controlling the stimulation of estrogen production which comprises:
Dependencies are inferred from the claim text.